http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2017066075-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ea6c094eb988e6315eed8f17b50e7af6 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-02 |
| filingDate | 2015-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_055d4fb1bb470a2ca8591a357024a2b6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b048e09d87889d0bba5610589b49f713 |
| publicationDate | 2017-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2017066075-A |
| titleOfInvention | Rheumatic drug |
| abstract | [PROBLEMS] To provide a therapeutic agent for rheumatism that has immediate effect and has a long-lasting effect of joint destruction for more than one month. By using a sugar steroid compound in which position 21 of desisobutyryl ciclesonide, which is an active metabolite of ciclesonide, is substituted with an acylated monosaccharide, the joint is effective for a long period of one month or longer. It is a therapeutic agent for rheumatoid arthritis that has a destructive therapeutic effect. [Selection figure] None |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10668167-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10772970-B2 |
| priorityDate | 2015-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 69.